Company Overview
DRIK, a preclinical CRO provides an integrated platform for in vitro and in vivo studies for toxicology and efficacy testing. Our 3D models provide are an alternative for animal testing and are viable for several weeks. Our range of services include, CYP induction and inhibition, Drug-Drug Interaction, Genotoxicity, Efficacy studies Xenograft model, Mechanism of Toxicity, Dose Range Finding/Maximum Tolerated Dose, Acute, Sub-acute and Chronic Toxicology Testing.